L2M Program

Lab to Market (L2M) Program
🚀 Lab-to-Market (L2M) Program 2026

Accelerating Medical Device Innovation from Laboratory to Market

The Lab-to-Market (L2M) Program on Medical Device Development & Validation supports researchers and innovators in transforming laboratory-stage healthcare technologies into validated, scalable, and commercially viable products. The initiative focuses on technologies with Technology Readiness Level (TRL) 6 and above.

Program Highlights

Funding Support ₹1.5 Cr
Technology Readiness TRL 6+
Focus Domain Digital Healthcare
Commercialization Startup Support
📅 Submission Deadline

31 July 2026
5:00 PM (IST)

Program Overview

The L2M initiative bridges the gap between academic innovation and commercialization by enabling healthcare technologies to progress from validated laboratory prototypes to market-ready products through funding, technical validation, IP support, and industry collaboration.

Supporting the Next Generation of Healthcare Innovation

The initiative is designed for researchers, faculty members, innovators, and institutions developing advanced medical technologies. Projects demonstrating strong technical feasibility, commercial potential, and societal impact will receive comprehensive support throughout their translation journey.

Prototype Validation

Technology readiness and performance evaluation.

Commercial Readiness

Product enhancement for market deployment.

Industry Connect

Mentorship and commercialization guidance.

Innovation Support

End-to-end translational ecosystem.

Program Offers

  • Financial support up to INR 150 Lakhs
  • Technology enhancement & product validation
  • Patent filing, licensing and commercialization assistance
  • Entrepreneurship & startup support
  • Field deployment and translational ecosystem
  • Industry collaboration opportunities

Funding Highlights

Selected projects receive comprehensive financial, technical and commercialization support to accelerate market adoption.

₹150L

Funding Support

Eligible projects may receive financial assistance of up to INR 150 Lakhs.

IP

Intellectual Property

Patent filing, licensing strategy and commercialization assistance.

TRL

Technology Validation

Support for prototype validation, testing and deployment.

🚀

Startup Enablement

Entrepreneurship guidance, incubation and market acceleration.

Priority Areas

The program focuses on high-impact Digital Healthcare technologies capable of addressing real-world clinical and societal challenges.

Medical Devices & Smart Healthcare

  • AI-enabled Medical Devices
  • Embedded Healthcare Electronics
  • Smart Healthcare Systems

Wearables & Continuous Monitoring

  • Wearable Biosensors
  • Smart Patches
  • Portable Monitoring Devices
  • Cardiac Monitoring
  • Respiratory Monitoring
  • Maternal & Neonatal Monitoring
  • Elderly & Home-care Solutions

Sensors & Data Acquisition

  • Physiological Signal Acquisition Systems
  • Healthcare Sensors
  • Patient Data Collection Technologies

Point-of-Care Diagnostics

  • Portable Diagnostic Devices
  • Biosensing Diagnostics
  • Low-cost Diagnostics
  • Non-invasive Diagnostic Tools

Who Can Apply?

The Lab-to-Market (L2M) Program welcomes researchers, faculty members, and institutions working on innovative healthcare technologies with strong commercialization potential.

🎓

Higher Education Institutions

Universities, IITs, NITs, IIITs, engineering colleges, medical colleges, and other recognized higher education institutions across India.

🔬

Research Institutes

Government and private research organizations working on Digital Healthcare, Medical Devices and Cyber Physical Systems.

👨‍🔬

Faculty & Researchers

Faculty members, scientists and researchers developing technologies with Technology Readiness Level (TRL) 6 or above.

🚀

Principal Investigators

Principal Investigators interested in translating laboratory prototypes into commercially viable healthcare products.

Applicants should demonstrate

  • ✔ Technology Readiness Level (TRL) 6 or above
  • ✔ Clear market understanding
  • ✔ Competitor analysis
  • ✔ Commercialization roadmap
  • ✔ Societal impact of the proposed technology
  • ✔ Strong innovation and technical feasibility

Application Process

Submit your proposal online by following these simple steps.

1

Prepare Your Proposal

Prepare the required project details and presentation in the prescribed format, highlighting innovation, market opportunity and commercialization potential.

2

Submit Online

Upload the proposal and presentation through the official online application portal before the submission deadline.

3

Technical Evaluation

Shortlisted applicants will be invited to present their technology before internal and external domain experts for technical assessment.

4

Investment Committee Review

Final evaluation by the External Investment Committee (EIC) consisting of experts from academia and industry.

5

Project Approval

Selected proposals receive funding support along with validation, commercialization and startup assistance.

Important Timeline

Mark these important dates to ensure your proposal is submitted on time.

📢

Applications Open

Applications are now open for the Lab-to-Market (L2M) Program.

📅

Submission Deadline

31 July 2026

5:00 PM (IST)

📝

Technical Evaluation

Shortlisted proposals will be invited for presentation before the expert committee.

🚀

Project Announcement

Final selected projects will receive funding and commercialization support.

Need Assistance?

Our team is here to help you with any questions related to the program or application process.

🏢

Organized By

IITI DRISHTI CPS Foundation
IIT Indore

Lab to Market (L2M) Program

Ready to Transform Your Healthcare Innovation into a Market-Ready Product?

Join India's leading translational healthcare innovation program and accelerate your journey from laboratory research to real-world impact.

Frequently Asked Questions

Everything You Need to Know

Find answers to common questions about eligibility, funding, project selection, commercialization, intellectual property, evaluation process and more.

Showing all FAQs